Authors:
Keyszer, G
Lambiri, I
Nagel, R
Keysser, C
Keysser, M
Gromnica-Ihle, E
Franz, J
Burmester, GR
Jung, K
Citation: G. Keyszer et al., Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers, J RHEUMATOL, 26(2), 1999, pp. 251-258
Authors:
Baerwald, CGO
Wahle, M
Ulrichs, T
Jonas, D
von Bierbrauer, A
von Wichert, P
Burmester, GR
Krause, A
Citation: Cgo. Baerwald et al., Reduced catecholamine response of lymphocytes from patients with rheumatoid arthritis, IMMUNOBIOL, 200(1), 1999, pp. 77-91
Citation: F. Buttgereit et al., Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: A novel glucocorticoid hierarchy, BIOCH PHARM, 58(2), 1999, pp. 363-368
Authors:
Backhaus, M
Kamradt, T
Sandrock, D
Loreck, D
Fritz, J
Raber, H
Hamm, B
Burmester, GR
Bollow, M
Citation: M. Backhaus et al., Arthritis of the finger joints - A comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging, ARTH RHEUM, 42(6), 1999, pp. 1232-1245
Authors:
Feist, E
Kuckelkorn, U
Dorner, T
Donitz, H
Scheffler, S
Hiepe, F
Kloetzel, PM
Burmester, GR
Citation: E. Feist et al., Autoantibodies in primary Sjogren's syndrome are directed against proteasomal subunits of the alpha and beta type, ARTH RHEUM, 42(4), 1999, pp. 697-702
Authors:
Hansen, A
Feist, E
Hiepe, F
Burmester, GR
Scholze, J
Citation: A. Hansen et al., Diffuse infiltrative lymphocytosis syndrome in a patient with anti-52-kd Ro/SSA and human immunodeficiency virus type 1, ARTH RHEUM, 42(3), 1999, pp. 578-580
Citation: F. Buttgereit et al., Further thoughts on the immunomodulatory role of glucocorticoids: comment on the article by Buttgereit et al - Reply, ARTH RHEUM, 42(2), 1999, pp. 395-396
Authors:
Furst, DE
Breedveld, FC
Burmester, GR
Crofford, L
Emery, P
Feldman, M
Kalden, JR
Kavanaugh, A
Keystone, E
Lipsky, EP
Maini, RN
Moreland, L
Smolen, JS
Van de Putte, L
Smolen, JS
Van de Putte, L
Vischer, T
Weinblatt, M
Weissman, M
Citation: De. Furst et al., Access to disease modifying treatments for rheumatoid arthritis patients, ANN RHEUM D, 58, 1999, pp. 129-130
Authors:
Keyszer, G
Lambiri, I
Keysser, M
Keysser, C
Nagel, R
Burmester, GR
Jung, K
Citation: G. Keyszer et al., Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity, Z RHEUMATOL, 57(6), 1998, pp. 392-398